Lincoln Pharmaceuticals Ltd saw a 5% share rise following its strong Q1 FY25 performance. The company reported a consolidated net profit of ₹23.5 crores, up 24% from the same quarter last year, and a total revenue of ₹147 crores, reflecting a 9% increase. Lincoln Pharmaceuticals Limited (LPL) is engaged in the business of manufacturing, marketing, and distribution of pharmaceutical products.